Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions.
- Author:
Miao YU
1
;
Cheng-Yan DENG
Author Information
1. Department of Obstetrics and Gynecology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Anti-Mullerian Hormone;
blood;
Biomarkers;
blood;
Female;
Fertilization in Vitro;
Follicle Stimulating Hormone;
blood;
Humans;
Ovarian Follicle;
physiology;
Ovarian Hyperstimulation Syndrome;
prevention & control;
Ovary;
physiology;
Polycystic Ovary Syndrome;
blood
- From:
Acta Academiae Medicinae Sinicae
2009;31(1):114-119
- CountryChina
- Language:Chinese
-
Abstract:
Anti-Müllerian hormone (AMH) is a member of the transforming growth factor (TGF)-beta superfamily and mainly expressed by the granulosa cells of ovarian follicles. In women AMH is only expressed in ovarian follicles and therefore can be used for the evaluation of the ovarian reserve function and the prediction of ovary ageing and ovarian response during in vitro fertilization (IVF) treatment. This article summarizes the clinical application of AMH, especially in evaluating ovarian reserve functions.
